NCT05821010View on ClinicalTrials.gov

Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 17, 2023

Primary Completion Date

February 20, 2026

Study Completion Date

August 20, 2026

Conditions
Non Alcoholic SteatohepatitisNon-Alcoholic Fatty Liver DiseaseFecal Microbiota TransplantationFMTPrebioticsProbioticsMicrobiomeIntestinal MicrobiomeGut Microbiome
Interventions
COMBINATION_PRODUCT

Lyophilized fecal microbiota transplantation capsules

Oral administration (capsule)

COMBINATION_PRODUCT

Placebo capsules

Oral administration (capsule)

DIETARY_SUPPLEMENT

A. soehngenii

Oral administration (capsule)

DIETARY_SUPPLEMENT

Pasteurized A. muciniphila

Oral administration (capsule)

DIETARY_SUPPLEMENT

B. animalis subsp. lactis

Oral administration (capsule)

DIETARY_SUPPLEMENT

Fructo-oligosaccharides

Oral administration (dissolved in water)

Trial Locations (1)

1105AZ

RECRUITING

Amsterdam UMC, Amsterdam

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER